Showing results (1-10 of 252) with videos related to
Sort By:
Pageof 26
Oncotarget|February 10, 2011
The anti-apoptotic members of the Bcl-2 family are attractive tumor-associated antigensPer Thor Straten, Mads Hald AndersenNature Reviews. Drug Discovery|May 3, 2005
Regulators of apoptosis: suitable targets for immune therapy of cancerMads Hald Andersen, Jürgen C Becker, Per thor StratenCancer Immunology, Immunotherapy : CII|December 26, 2013
Self-reactive T cells: suppressing the suppressorsJürgen C Becker, Per thor Straten, Mads Hald AndersenJournal of Skin Cancer|July 21, 2011
Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical applicationNiels Junker, Per Thor Straten, Mads Hald Andersen, et al.Scandinavian Journal of Gastroenterology|January 5, 2012
Immunotherapy for metastatic colorectal cancer: present status and new optionsEva Ellebaek, Mads Hald Andersen, Inge Marie Svane, et al.Journal of Translational Medicine|April 10, 2004
T-cell clonotypes in cancerPer Thor Straten, David Schrama, Mads Hald Andersen, et al.Cancer Immunology, Immunotherapy : CII|May 14, 2013
Immune-suppressive properties of the tumor microenvironmentJürgen C Becker, Mads Hald Andersen, David Schrama, et al.The Journal of Investigative Dermatology|March 11, 2004
The melanoma inhibitor of apoptosis protein: a target for spontaneous cytotoxic T cell responsesMads Hald Andersen, Sine Reker, Jürgen C Becker, et al.The Journal of Investigative Dermatology|January 19, 2006
Cytotoxic T cellsMads Hald Andersen, David Schrama, Per Thor Straten, et al.Journal of Translational Medicine|September 5, 2006
HLA-A24 and survivin: possibilities in therapeutic vaccination against cancerMads Hald Andersen, Rikke B Soerensen, Jürgen C Becker, et al.Pageof 26